Journal Guide

Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal contains a series of timely in-depth reviews, research articles and letters written by leaders in the field covering a range of current topics in both pre-clinical and clinical areas of Pharmaceutical Biotechnology. Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.

Current Pharmaceutical Design publishes timely in-depth reviews and research articles from leading pharmaceutical researchers in the field, covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area guest edited by an acknowledged authority in the field.

Current Pharmacogenomics and Personalized Medicine (CPPM) is a transdisciplinary peer-reviewed biomedical journal that reports new findings and cutting-edge concepts in both pharmacogenomics and personalized medicine under a single cover. CPPM is an accelerator for global personalized medicine and pharmacogenomics. Importantly, the journal provides a multi-disciplinary integrated platform from cell to society to address diagnostics and responsible pharmacogenomics applications in developing countries.

Current Physical Chemistry publishes research articles, full-length/mini reviews, and topical issues on the important recent developments in physical chemistry and allied disciplines.
The scope of the journal covers all areas of physical chemistry, including surface science, colloids and interfaces, thermodynamics, spectroscopy, molecular structure, solid state chemistry, catalysis, kinetics, theoretical chemistry, chemical physics and biophysical chemistry.

Fundamental plant sciences is increasingly becoming a collaborative domain, with projects for example including physics, mathematics and chemistry. This is largely fuelled by the last decade's many technical advances, allowing for more discoveries but also creating new challenges, such as data storage, analysis and predictions. Interdisciplinary collaborations are often the solution to these challenges.

This journal aims to acknowledge and encourage interdisciplinary research in fundamental plant sciences. It will publish original research papers and method papers in plant research fields such as systems biology, cell biology, genetics, epigenetics, mathematical modeling, omics, signal transduction, plant-microbe interactions, synthetic biology, developmental biology, biochemistry, bioinformatics research, and big data in plant biology. High-quality review articles are also welcome.

To further encourage collaboration in the community, all accepted authors of Research articles are required to make their data accessible to the public. This will avoid duplicate projects and speed up the progress of science. The journal will actively link and cooperate with some of these databases, as well as with computational infrastructure. Data should always be submitted in raw data format, and should be submitted preferentially in publicly accessible resources maintained by for example EBI, EMBL, or NCBI data. Which data repository is used is up to the authors, however please visit http://www.elsevier.com/databaselinking for more information on depositing and linking your data with a supported data repository. For datatypes for which no such repositories exist, data should be made available through the supplementary information or the authors own website. If the data has been processed into e.g. pathways or models, then this should be made available also during the review process.

For more submission information, see our Guide for Authors.

The editorial and publishing team of the journal is dedicated to being efficient in the manuscript handling. The journal uses a double-blinded peer review, to avoid bias in the review process. The resulting publications will be open access.

The journal is devoted to all aspects of science and technology of prebiotics including functionalities and performance, analytical methodology, and applications relevant to humans, animals and plants.

Each bimonthly issue of Current Problems in Cancer presents a single-topic, in-depth discussion, usually focused on the integrated management of a particular type of cancer or on a problem faced in a wide variety of malignancies. Issues may explore a particular category of drugs, an emerging interventional technique, or rehabilitation/reconstruction. Extensive bibliographies allow readers to easily locate additional information on related topics. Current Problems in Cancer serves the wide spectrum of physicians who treat patients with neoplastic disease.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.If you require any further information or help, please visit our support pages: http://support.elsevier.com

Under the editorial leadership of noted cardiologist Dr. Shahbudin Rahimtoola, Current Problems in Cardiology provides focused, comprehensive coverage of important clinical topics in cardiology. Each monthly issues, addresses a selected clinical problem or condition, including pathophysiology, invasive and noninvasive diagnosis, drug therapy, surgical management, and rehabilitation; or explores the clinical applications of a diagnostic modality or a particular category of drugs. Critical commentary from the distinguished editorial board accompanies each monograph, providing readers with additional insights. An extensive bibliography in each issue saves hours of library research.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.